956
The second is a 29-year-old man with CD in whom nodular sclerosing Hodgkin's lymphoma was diagnosed 3 weeks after infusion with infliximab.
 a 29-year-old man with CD: Subject; 29-year-old: Subject.Age; man: Subject.Gender; nodular sclerosing Hodgkin's lymphoma: Effect; 3 weeks after infusion with infliximab: Treatment; CD: Treatment.Disorder; 3 weeks: Treatment.Time_elapsed; infusion: Treatment.Route; infliximab: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a 29-year-old man with CD: Subject; 29-year-old: Subject.Age; man: Subject.Gender; nodular sclerosing Hodgkin's lymphoma: Effect; 3 weeks after infusion with infliximab: Treatment; CD: Treatment.Disorder; 3 weeks: Treatment.Time_elapsed; infusion: Treatment.Route; infliximab: Treatment.Drug